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Background
Several studies reported altered expression of the water
channels, aquaporins (AQPs), in brains of Alzheimer’s dis-
ease (AD) but the relevance of the observed changes with
respect to the neuropathology of AD is poorly understood.
Because aberrant processing of the amyloid precursor pro-
tein (APP) to amyloid beta-peptide (A-beta), the principle
component of amyloid plaques, is central to the pathogen-
esis of AD, we sought to determine the temporal and spa-
tial expression of AQPs in the cortex and hippocampus of
the triple transgenic mouse model of Alzheimer’s disease
(3xTg-AD) and to elucidate whether AQPs contribute
directly to the aberrant processing of APP into A-beta.
Materials and methods
We used a mutant strain 3xTg AD mice, which harbor
the human presenilin1 (PS1 M146V), APP (APPSwe) and
tau (tauP301L) transgenes and develop age-dependent
accumulation of both plaques and tangle pathologies in a
pattern consistent with AD. Cortex and hippocampus
(free of choroid plexus) were harvested from 2, 6 and
14 month-old 3xTg AD and wild type (C57) mice. AQP1
and AQP4 protein expression was quantified by immu-
noblotting, and immunohistochemistry was performed
on frozen sections probed with anti-AQP1 and anti-
AQP4 antibodies. AQP1 and AQP4 mRNA expression
was measured by real-time PCR.
Results
AQP1 but not AQP4 was detected at significantly
higher levels in 3xTg-AD mice at 12 months when
compared with younger mice at 2 and 6 months of
age. No significant changes in the expression of AQP1
and AQP4 were observed at any ages in non-transgenic
control mice. Immunohistochemical analyses to deter-
mine co-localization of AQP1 with APP in neurons (in
12 month-old 3xTg-AD mice) are being undertaken.
Our findings correlate with published data suggesting
amyloid clearance abnormalities in chronic and normal
pressure hydrocephalus.
Conclusions
Our findings show increased expression of AQP1 in the
brains of older 3xTg-AD but not non-transgenic control
mice. This finding is consistent with published data of
AQP1 in AD, and maybe related to similar findings in
chronic or normal pressure hydrocephalus. Increased
AQP1 expression in late stages of AD may possibly con-
tribute to aberrant APP processing, and warrants further
study.
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